12-Year-Old Boy With Chronic Budd-Chiari Syndrome, Presenting With Recurrent Abdominal Pain and Distention, After Undergoing Left Hepatic Vein Angioplasty.

12-Year-Old Boy With Chronic Budd-Chiari Syndrome, Presenting With Recurrent Abdominal Pain and Distention, After Undergoing Left Hepatic Vein Angioplasty. Liver stiffness measurement before (A) and 24 hours after (B) intervention shows a decrease from 44.1 kPa to 26.4 kPa.


October 6, 2021 — According to ARRS’ American Journal of Roentgenology (AJR), liver stiffness measurements (LSM) obtained by 2D shear-wave elastography (SWE) may serve as a useful quantitative adjunct to Color Doppler ultrasound (CDUS) in monitoring children with chronic Budd-Chiari syndrome (BCS) for disease recurrence after percutaneous interventional treatment.

“LSM decreased significantly after image-guided intervention for chronic BCS in children, showing a maximal decrease at 24 hours post-intervention,” wrote corresponding author Sanjay Sharma from the department of radiodiagnosis and interventional radiology at the All India Institute of Medical Sciences in New Delhi. “Disease recurrence was typically associated with an increase in LSM, compared with the patient’s prior measurement.”

Sharma and team’s prospective study included children with chronic BCS and planned image-guided intervention. CDUS and 2D SWE were performed at baseline; at 24 hours, one month, and three months after intervention; and thereafter every three months or at the time of clinically suspected recurrence.

In the 32 children (28 boys, 4 girls; mean age, 9.0 years) who underwent image-guided intervention for chronic BCS, median LSM was 43.7 kPa at baseline and 22.5 kPa, 18.7 kPa, and 16.7 kPa at 24 hours, one month, and three months, respectively, after intervention. In eight of nine patients with recurrence, LSM was increased, compared with the pre-recurrence measurement.

“The stage of histologic liver fibrosis was not significantly correlated with LSM at any time point, possibly due to the confounding effect of liver congestion,” added the authors of this AJR article.

For more information: www.arrs.org


Related Content

News | Artificial Intelligence

March 1, 2024 — Royal Philips, a global leader in health technology, and magnetic resonance imaging (MRI) software ...

Time March 01, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Cardiac Imaging

February 28, 2024 — Royal Philips, a global leader in health technology, announced major enhancements to its Image ...

Time February 28, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

February 28, 2024 — Royal Philips, a global leader in health technology, today announced a significant milestone as it ...

Time February 28, 2024
arrow
News | Artificial Intelligence

February 27, 2024 — As artificial intelligence (AI) is increasingly used in radiology, researchers caution that it’s ...

Time February 27, 2024
arrow
News | X-Ray

February 26, 2024 — AIxSCAN, Inc. began clinical trials in late 2023. The AIxSCAN, Inc. team is very pleased with the ...

Time February 26, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

February 21, 2024 — Hyperfine, Inc., a groundbreaking health technology company that has redefined brain imaging with ...

Time February 21, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

February 16, 2024 — Fujifilm Healthcare Europe will be presenting the Echelon Synergy – a revolutionary MRI scanner for ...

Time February 16, 2024
arrow
News | SPECT Imaging

February 15, 2024 — According to a release issued by the U.S. Food and Drug Administration (FDA), Philips is recalling ...

Time February 15, 2024
arrow
News | Ultrasound Imaging

February 15, 2024 — Clarius Mobile Health, a global leader in wireless ultrasound solutions, announces T-Mode AI, a ...

Time February 15, 2024
arrow
Subscribe Now